Table 2 Treatment of cases

Radiotherapy (RT) (N = 133)

10 × 3 Gy

77

57.9%

14 × 2.5 Gy

20

15.1%

20 × 2 Gy

34

25.6%

Others

2

1.5%

Systemic therapy prior to RT

Chemotherapy

46

34.1%

Endocrine therapy

47

34.8%

Bisphosphonates

51

37.8%

Systemic therapy after RT

Chemotherapy

72

53.3%

Endocrine therapy (N = 30)

26

86.7%

Bisphosphonates

123

91.1.%